Aemetis (NASDAQ: AMTX) is one of 25 publicly-traded companies in the “Industrial organic chemicals” industry, but how does it compare to its rivals? We will compare Aemetis to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, dividends, earnings, profitability and valuation.
Risk and Volatility
Aemetis has a beta of -0.67, suggesting that its share price is 167% less volatile than the S&P 500. Comparatively, Aemetis’ rivals have a beta of 0.49, suggesting that their average share price is 51% less volatile than the S&P 500.
This table compares Aemetis and its rivals’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Earnings & Valuation
This table compares Aemetis and its rivals top-line revenue, earnings per share and valuation.
Aemetis’ rivals have higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of recent ratings and price targets for Aemetis and its rivals, as reported by MarketBeat.com.
||Strong Buy Ratings
Aemetis currently has a consensus price target of $2.00, suggesting a potential upside of 37.93%. As a group, “Industrial organic chemicals” companies have a potential upside of 15.18%. Given Aemetis’ higher probable upside, analysts plainly believe Aemetis is more favorable than its rivals.
Insider and Institutional Ownership
16.2% of Aemetis shares are owned by institutional investors. Comparatively, 53.2% of shares of all “Industrial organic chemicals” companies are owned by institutional investors. 24.1% of Aemetis shares are owned by company insiders. Comparatively, 14.2% of shares of all “Industrial organic chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Aemetis rivals beat Aemetis on 10 of the 13 factors compared.
Aemetis, Inc. operates as an international renewable fuels and bio-chemicals company in North America and India. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries. The company owns and operates a biodiesel plant in Kakinada, India; and an ethanol plant in Keyes, California. Aemetis, Inc. sells biodiesel and glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.